Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy
Jessica Dahmus, Michelle Rosario, Kofi Clarke Gastroenterology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USACorrespondence: Kofi Clarke Tel +1 717-531-8741Fax +1 717-531-6770Email kclarke@pennstatehealth.psu.eduAbstract: Anti-tumor necrosis factor alpha (ATA) therapy plays a signifi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-09-01
|
| Series: | Clinical and Experimental Gastroenterology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/risk-of-lymphoma-associated-with-anti-tnf-therapy-in-patients-with-inf-peer-reviewed-article-CEG |